Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: nitric oxide-donating compounds - NicOx

Drug Profile

Research programme: nitric oxide-donating compounds - NicOx

Alternative Names: HCT 2037; NCX 1236; NCX 226; NCX 429; NCX 6550; NCX 8001; NCX 976

Latest Information Update: 31 Jul 2012

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator NicOx
  • Class Nitrates
  • Mechanism of Action Cyclooxygenase inhibitors; Endothelin receptor antagonists; Nitric oxide donors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • Available For Licensing Yes

Highest Development Phases

  • Discontinued Bacterial infections; Cancer; Diabetic retinopathy; Hypertension; Inflammation; Metabolic disorders; Osteoarthritis; Pain; Pulmonary arterial hypertension; Viral infections

Most Recent Events

  • 27 Jul 2012 Discontinued - Preclinical for Inflammation in France (unspecified route)
  • 27 Jul 2012 Discontinued - Preclinical for Pulmonary hypertension in France (unspecified route)
  • 27 Jul 2012 Discontinued for Diabetic retinopathy in France (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top